Hørslev-Petersen K - Search Results

1

Predictors of joint damage progression and stringent remission in patients with established rheumatoid arthritis in clinical remission.

Møller-Bisgaard S, Georgiadis S, Hørslev-Petersen K, Ejbjerg B, Hetland ML, Ørnbjerg LM, Glinatsi D, Møller J, Boesen M, Stengaard-Pedersen K, Madsen OR, Jensen B, Villadsen JA, Hauge EM, Bennett P, Hendricks O, Asmussen K, Kowalski M, Lindegaard H, Bliddal H, Krogh NS, Ellingsen T, Nielsen AH, Balding L, Jurik AG, Thomsen HS, Østergaard M. Møller-Bisgaard S, et al. Rheumatology (Oxford). 2021 Jan 5;60(1):380-391. doi: 10.1093/rheumatology/keaa496. Rheumatology (Oxford). 2021. PMID: 32929463 Clinical Trial.

2

Serum aminoterminal type III procollagen peptide in early rheumatoid arthritis: relation to disease activity and progression of joint damage.

Eberhardt K, Thorbjorn Jensen L, Horslev-Petersen K, Pettersson H, Lorenzen I, Wollheim F. Eberhardt K, et al. Clin Exp Rheumatol. 1990 Jul-Aug;8(4):335-40. Clin Exp Rheumatol. 1990. PMID: 2204510

3

Urinary hydroxypyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone.

Kollerup G, Hansen M, Hørslev-Petersen K. Kollerup G, et al. Br J Rheumatol. 1994 Sep;33(9):816-20. doi: 10.1093/rheumatology/33.9.816. Br J Rheumatol. 1994. PMID: 8081665 Clinical Trial.

4

Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment.

Hansen M, Florescu A, Stoltenberg M, Pødenphant J, Pedersen-Zbinden B, Hørslev-Petersen K, Hyldstrup L, Lorenzen I. Hansen M, et al. Scand J Rheumatol. 1996;25(6):367-76. doi: 10.3109/03009749609065648. Scand J Rheumatol. 1996. PMID: 8996471

5

Serum YKL-40 concentrations in patients with rheumatoid arthritis: relation to disease activity.

Johansen JS, Stoltenberg M, Hansen M, Florescu A, Hørslev-Petersen K, Lorenzen I, Price PA. Johansen JS, et al. Rheumatology (Oxford). 1999 Jul;38(7):618-26. doi: 10.1093/rheumatology/38.7.618. Rheumatology (Oxford). 1999. PMID: 10461474

6

A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gömör B, Van Den Bosch F, Nordström D, Bjorneboe O, Dahl R, Horslev-Petersen K, Rodriguez De La Serna A, Molloy M, Tikly M, Oed C, Rosenburg R, Loew-Friedrich I. Emery P, et al. Rheumatology (Oxford). 2000 Jun;39(6):655-65. doi: 10.1093/rheumatology/39.6.655. Rheumatology (Oxford). 2000. PMID: 10888712 Clinical Trial.

7

Low field dedicated magnetic resonance imaging in untreated rheumatoid arthritis of recent onset.

Lindegaard H, Vallø J, Hørslev-Petersen K, Junker P, Østergaard M. Lindegaard H, et al. Ann Rheum Dis. 2001 Aug;60(8):770-6. doi: 10.1136/ard.60.8.770. Ann Rheum Dis. 2001. PMID: 11454641 Free PMC article.

8

[Diagnosis and treatment of early rheumatoid arthritis].

Jacobsen S, Skjødt H, Hørslev-Petersen K, Hansen TM, Sørensen SF, Petersen J, Junker P, Stengaard-Pedersen K. Jacobsen S, et al. Ugeskr Laeger. 2002 Feb 18;164(8):1060-1. Ugeskr Laeger. 2002. PMID: 11894713 Danish. No abstract available.

9

Can magnetic resonance imaging differentiate undifferentiated arthritis?

Østergaard M, Duer A, Hørslev-Petersen K. Østergaard M, et al. Arthritis Res Ther. 2005;7(6):243-5. doi: 10.1186/ar1844. Epub 2005 Oct 13. Arthritis Res Ther. 2005. PMID: 16277699 Free PMC article.

10

[Early referral and treatment of patients with acute arthritis. Experiences from two early arthritis clinics].

Lindegaard HM, Hørslev-Petersen K, Junker P. Lindegaard HM, et al. Ugeskr Laeger. 2005 Nov 21;167(47):4458-61. Ugeskr Laeger. 2005. PMID: 16305765 Danish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

205 results

Search Page